C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 3/00 (2006.01) C12N 5/073 (2010.01) C12N 5/075 (2010.01) C12N 5/076 (2010.01) A61K 35/54 (2006.01) C12M 3/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/48 (2006.01)
Patent
CA 2632869
The present invention relates to a method for determining the ideal time for and outcome of reproductive health procedures including in vitro fertilization by establishing a correlation between the successful outcome of said procedure and the spectra of a body fluid obtained using a chosen analytical modality for a population of patients, acquiring for a patient a spectrum of the body fluid of the patient using said chosen modality.
L'invention concerne un procédé permettant de déterminer le moment idéal pour des procédures de santé de la reproduction et le résultat de celles-ci, notamment une fécondation in vitro, par établissement une corrélation entre le résultat réussi de la procédure et le spectre d'un fluide corporel obtenu au moyen d'une modalité analytique choisie pour une population de patients et par acquisition pour un patient d'un spectre du fluide corporel du patient au moyen de la modalité choisie.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
University Mcgill
LandOfFree
Metabolomic determination in assisted reproductive technology does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metabolomic determination in assisted reproductive technology, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolomic determination in assisted reproductive technology will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1523675